Effective implementation of oxygen therapy in interstitial lung disease requires more robust scientific evidence, technological innovation, equitable funding models, and access to information and support to empower users.
Read the pick of the week | Submit your manuscript to the European Respiratory Review
No comments:
Post a Comment